Tuesday, 17 February 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 17 February 2026
IQVIA
IQVIA
Judge shields $130M AZ market

An 'unprecedented' lightning-quick court ruling has seen AstraZeneca granted an injunction to protect its most important market in Australia - worth $130 million-plus a year - from generic competition.

Disruptor debuts on private script
But the company is hoping for a nod from the PBAC in March recommending reimbursement for this game-changing treatment
TODAY
New Leadership Summit unveiled
Medicines Australia and AusBiotech are building on the success of this annual event with a new initiative
TODAY
PiF Survey
PiF Survey
Ex-Syd exec lands dream job
From GSK, to Google, to Forbes 30 Under 30, this former Sydney pharma marketer has just made another meteoric career move
16 February
Retiring after 51 years in pharma
Dubbed the 'First Lady of Australian Pharma' this pharma executive has retired after more than five decades in the business
13 February
CEO dumped... rival takes over
Sanofi has ousted its CEO in favour of a high-flyer who left the company 15 years ago and has been at the helm of a rival large pharma
13 February
Redundancy double whammy hits
Two Australian Big Pharmas have started 2026 with slimmed down teams plus the other most popular stories this week
13 February Your Week in 5 Minutes
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (14)

Access & Reimbursement (1)

Clinical & Medical, R&D (4)

Regulatory, Pharmacovigilance & QA (4)

Executive Roles (1)

Other (17)

Nice work, CEO wins 30% pay rise
Commended for 'exceptional leadership' and experience which enabled this company to exceed its long-term financial targets
16 February
Aussies tap ex-global pharma exec
Chimeric nabs CAR T high-flyer following a worldwide recruitment process that identified over 30 potential candidates
16 February
Innovators block biosim spread
Government data reveals that overall biosimilars have not taken market share from original brands despite a surge in listings
16 February
First generic of MSD drug approved
Newcomer faces slim competition in the space plus Pfizer expands its antidepressant offering with a tablet bottle option
16 February Approvals Action
PBS safe from Trump's MFN
Pharmas are still listing drugs on the PBS despite claims Trump's policies will see them avoid Australia, according to the DoH
13 February
AZ eyes 25-plus blockbusters
The company doubles down on its goal to deliver US$80 billion in total revenue by 2030 with key launches on the horizon
13 February
Aussie pharma 'drowning' in change
Pharma teams are buckling under change overload to meet shifting market dynamics and it's eroding performance and the bottom line
12 February
Pfizer, Arrotex partner on biologic
Partnership will see Arrotex represent the drug in community and hospital pharmacies, and with prescribers
12 February
HCPs name best vaccine maker
A survey has revealed which pharma has the best reputation among HCPs when it comes to vaccines at a time when sales could collapse
12 January
PBAC in court for saying 'No'
In a David and Goliath battle a small Aussie pharma is challenging the failure by PBAC to recommend its drug for a PBS listing
12 February
Biotech debuts GM drug in Aust
A young Canadian company has been given the go-ahead by the gene regulator to conduct a world first in-human clinical trial
12 February
Meet the Best CEOs in pharma
Pharmas are some of the largest and most complex companies to run, these CEOs are helming some absolute behemoths
11 February
Why CSL's CEO simply had to go
The Board didn't hold back when delivering an explanation for the abrupt departure of Paul McKenzie after just three years in the job
11 February
Company quietly cuts Aussie jobs
There have been an undisclosed number of layoffs at this Big Pharma but the company is staying tightlipped on the details
11 February
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.